The Lancet Global Health · 2019 · 38 citations · 14 references
MedicineMaternal HealthPreventive MedicineContraceptionContraceptive CounselingReproductive HealthContraception CounselingContraceptive CareContraceptive EffectivenessContraceptive MethodsContraceptive UsePostpartum ContraceptionContraceptive Prevalence RateContraceptive Use PrevalenceControl Group DesignFamily Planning UseImplementation In Low-resource SettingsModern Contraceptive UsePostpartum Contraceptive UsePrimary Outcome Analysis
BACKGROUND: Post-partum family planning services can prevent maternal and child morbidity and mortality in low-resource settings. We assessed the effect of a family planning intervention package on modern contraceptive use at 12 months post partum in predominantly rural Burkina Faso. METHODS: Yam Daabo was a two group, multi-intervention, single-blinded, cluster randomised controlled trial. Primary health-care centres were randomly allocated to intervention or control clusters in a 1:1 ratio with only data analysts masked to the allocation assignment. Interventions comprised refresher training for the provider, a counselling tool, supportive supervision, availability of contraceptive services 7 days a week, client appointment cards, and invitation letters for partners. The primary outcome was modern contraceptive prevalence at 12 months, and secondary outcomes were modern contraceptive prevalence at 6 weeks and 6 months post partum. Analysis was by modified intention to treat. Prevalence ratios were adjusted for cluster effects and baseline characteristics. This study was registered with the Pan-African Clinical Trials Registry (PACTR201609001784334). FINDINGS: From July 27-Oct 17, 2016, eight clinics were randomised and 571 women were enrolled and allocated: 286 to four intervention clusters and 285 to four control clusters. Of these, 523 completed the 12-month study exit interview (260 in the intervention group, 263 in the control group) and 523 were included in the intention-to-treat analysis. At 12 months, modern contraceptive prevalence was 55% among women who received the package and 29% among those who received routine care in control clusters (adjusted prevalence ratio 1·79, 95% CI 1·30-2·47). Significant differences in modern contraceptive prevalence were also seen between intervention and control groups at 6 weeks (42% and 10%, respectively; adjusted prevalence ratio 3·88, 95% CI 1·46-10·35) and 6 months (59% and 24%, respectively; 2·31, 1·44-3·71). INTERPRETATION: A package of six low-technology interventions, aimed at strengthening existing primary health-care services and enhancing demand for these services, can effectively increase modern contraceptive use for up to a year post partum in rural settings in Burkina Faso and has the potential to be suitable in similar settings in this country and others. FUNDING: Government of France.
14
Medical-eligibility criteria for contraceptive use
John Guillebaud · The Lancet · 2001 · 1.1K citations
Niamh Cahill, Emily Sonneveldt, John Stover et al. · The Lancet · 2017 · 252 citations · Full text
Zhuzhi Moore, Anne Pfitzer, Rehana Gubin et al. · Contraception · 2015 · 219 citations · Full text